 Kristen Nordenholz
Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Embolism | 17 | 2021 | 241 | 2.250 |
Why?
| | Venous Thromboembolism | 7 | 2022 | 328 | 0.800 |
Why?
| | Fibrin Fibrinogen Degradation Products | 7 | 2016 | 92 | 0.700 |
Why?
| | Emergency Service, Hospital | 15 | 2021 | 2381 | 0.640 |
Why?
| | Emergency Medicine | 3 | 2023 | 282 | 0.390 |
Why?
| | Anticoagulants | 4 | 2021 | 748 | 0.390 |
Why?
| | Tissue Plasminogen Activator | 4 | 2017 | 248 | 0.390 |
Why?
| | Antithrombins | 1 | 2013 | 71 | 0.390 |
Why?
| | Emergency Treatment | 1 | 2013 | 123 | 0.370 |
Why?
| | Fibrinolytic Agents | 4 | 2017 | 297 | 0.370 |
Why?
| | gamma-Glutamyltransferase | 1 | 2012 | 42 | 0.360 |
Why?
| | Venous Thrombosis | 3 | 2016 | 196 | 0.340 |
Why?
| | Hemorrhage | 2 | 2014 | 822 | 0.290 |
Why?
| | Oximetry | 1 | 2009 | 125 | 0.280 |
Why?
| | Patient Care Team | 1 | 2014 | 696 | 0.270 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2008 | 92 | 0.250 |
Why?
| | Patient Acceptance of Health Care | 1 | 2014 | 881 | 0.250 |
Why?
| | Healthcare Disparities | 1 | 2014 | 735 | 0.250 |
Why?
| | Blood Proteins | 1 | 2008 | 239 | 0.240 |
Why?
| | Thromboembolism | 1 | 2007 | 129 | 0.240 |
Why?
| | Sensitivity and Specificity | 8 | 2016 | 1997 | 0.230 |
Why?
| | Burnout, Professional | 2 | 2023 | 488 | 0.230 |
Why?
| | Diagnostic Imaging | 2 | 2008 | 337 | 0.230 |
Why?
| | Prospective Studies | 14 | 2016 | 8057 | 0.190 |
Why?
| | Biomarkers | 3 | 2017 | 4295 | 0.170 |
Why?
| | Severity of Illness Index | 1 | 2009 | 2930 | 0.170 |
Why?
| | Mass Screening | 2 | 2021 | 1360 | 0.160 |
Why?
| | Middle Aged | 20 | 2022 | 36215 | 0.160 |
Why?
| | Muscarinic Antagonists | 1 | 2000 | 30 | 0.150 |
Why?
| | Drug Contamination | 1 | 2000 | 53 | 0.150 |
Why?
| | Renal Insufficiency | 1 | 2022 | 172 | 0.150 |
Why?
| | Heroin Dependence | 1 | 2000 | 33 | 0.150 |
Why?
| | Poisoning | 1 | 2000 | 119 | 0.140 |
Why?
| | Humans | 33 | 2023 | 145475 | 0.140 |
Why?
| | Respiratory Insufficiency | 1 | 2022 | 326 | 0.140 |
Why?
| | Male | 24 | 2022 | 72843 | 0.140 |
Why?
| | Thrombosis | 1 | 2022 | 400 | 0.130 |
Why?
| | Acute Disease | 3 | 2017 | 1036 | 0.130 |
Why?
| | Female | 24 | 2022 | 78845 | 0.130 |
Why?
| | Predictive Value of Tests | 4 | 2015 | 2121 | 0.130 |
Why?
| | Adult | 16 | 2021 | 40777 | 0.120 |
Why?
| | Rivaroxaban | 2 | 2021 | 271 | 0.120 |
Why?
| | Dyspnea | 2 | 2015 | 250 | 0.120 |
Why?
| | Ultrasonography | 2 | 2016 | 785 | 0.110 |
Why?
| | Abdominal Injuries | 1 | 1997 | 130 | 0.110 |
Why?
| | Risk Factors | 8 | 2021 | 10885 | 0.110 |
Why?
| | Physicians | 1 | 2023 | 955 | 0.110 |
Why?
| | Efficiency, Organizational | 1 | 2015 | 141 | 0.110 |
Why?
| | Radiology | 1 | 2016 | 174 | 0.100 |
Why?
| | Dabigatran | 1 | 2013 | 30 | 0.100 |
Why?
| | Heparin, Low-Molecular-Weight | 1 | 2013 | 37 | 0.100 |
Why?
| | beta-Alanine | 1 | 2013 | 25 | 0.100 |
Why?
| | Fibrinolysis | 1 | 2015 | 164 | 0.100 |
Why?
| | Quality of Life | 3 | 2015 | 3204 | 0.100 |
Why?
| | Wounds, Nonpenetrating | 1 | 1997 | 321 | 0.100 |
Why?
| | Thiophenes | 1 | 2013 | 117 | 0.100 |
Why?
| | Morpholines | 1 | 2013 | 130 | 0.100 |
Why?
| | Tomography, X-Ray Computed | 4 | 2015 | 2769 | 0.090 |
Why?
| | Benzimidazoles | 1 | 2013 | 189 | 0.090 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2015 | 248 | 0.090 |
Why?
| | Probability | 2 | 2014 | 307 | 0.090 |
Why?
| | Pyridones | 1 | 2013 | 209 | 0.090 |
Why?
| | Aged | 9 | 2021 | 26153 | 0.090 |
Why?
| | Diagnosis, Differential | 3 | 2015 | 1508 | 0.090 |
Why?
| | Administration, Oral | 1 | 2013 | 866 | 0.080 |
Why?
| | Radiation Injuries | 1 | 2012 | 149 | 0.080 |
Why?
| | Heparin | 1 | 2012 | 247 | 0.080 |
Why?
| | Decision Support Techniques | 1 | 2015 | 477 | 0.080 |
Why?
| | Pyrazoles | 1 | 2013 | 517 | 0.080 |
Why?
| | Medical History Taking | 1 | 2010 | 117 | 0.070 |
Why?
| | Retrospective Studies | 5 | 2022 | 17291 | 0.070 |
Why?
| | Physical Examination | 1 | 2010 | 243 | 0.070 |
Why?
| | False Negative Reactions | 1 | 2008 | 61 | 0.070 |
Why?
| | Peroxidase | 1 | 2008 | 168 | 0.070 |
Why?
| | Area Under Curve | 1 | 2008 | 331 | 0.070 |
Why?
| | Research Design | 1 | 2013 | 1137 | 0.060 |
Why?
| | Nephelometry and Turbidimetry | 1 | 2007 | 15 | 0.060 |
Why?
| | Quality of Health Care | 1 | 2012 | 692 | 0.060 |
Why?
| | Inflammation | 1 | 2017 | 2878 | 0.060 |
Why?
| | C-Reactive Protein | 1 | 2008 | 422 | 0.060 |
Why?
| | HIV Infections | 1 | 2021 | 3194 | 0.060 |
Why?
| | Electrocardiography | 1 | 2009 | 665 | 0.060 |
Why?
| | Observer Variation | 1 | 2007 | 357 | 0.060 |
Why?
| | Critical Care | 1 | 2012 | 702 | 0.060 |
Why?
| | Algorithms | 2 | 2008 | 1845 | 0.060 |
Why?
| | Logistic Models | 4 | 2012 | 2134 | 0.060 |
Why?
| | Odds Ratio | 3 | 2012 | 1082 | 0.050 |
Why?
| | Cohort Studies | 1 | 2014 | 6013 | 0.050 |
Why?
| | Risk Assessment | 2 | 2012 | 3747 | 0.040 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2022 | 115 | 0.040 |
Why?
| | Decision Trees | 1 | 2021 | 78 | 0.040 |
Why?
| | Faculty | 1 | 2022 | 147 | 0.040 |
Why?
| | Indiana | 1 | 2020 | 38 | 0.040 |
Why?
| | Symptom Assessment | 1 | 2022 | 136 | 0.040 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 229 | 0.040 |
Why?
| | Mid-Atlantic Region | 1 | 2000 | 3 | 0.040 |
Why?
| | Cough | 1 | 2021 | 124 | 0.040 |
Why?
| | Personal Satisfaction | 1 | 2022 | 219 | 0.040 |
Why?
| | Heroin | 1 | 2000 | 29 | 0.040 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2000 | 124 | 0.040 |
Why?
| | Fever | 1 | 2021 | 319 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2010 | 330 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2020 | 412 | 0.040 |
Why?
| | Double-Blind Method | 2 | 2014 | 2062 | 0.040 |
Why?
| | Adolescent | 4 | 2013 | 22530 | 0.030 |
Why?
| | Treatment Outcome | 4 | 2021 | 11772 | 0.030 |
Why?
| | Survival Analysis | 1 | 2021 | 1374 | 0.030 |
Why?
| | United States | 4 | 2021 | 16098 | 0.030 |
Why?
| | Hypertension, Pulmonary | 1 | 2009 | 1957 | 0.030 |
Why?
| | Convalescence | 1 | 2017 | 19 | 0.030 |
Why?
| | Multivariate Analysis | 2 | 2012 | 1547 | 0.030 |
Why?
| | Peritoneal Lavage | 1 | 1997 | 8 | 0.030 |
Why?
| | Controlled Clinical Trials as Topic | 1 | 1997 | 27 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2022 | 609 | 0.030 |
Why?
| | Health Personnel | 1 | 2023 | 754 | 0.030 |
Why?
| | Disease Outbreaks | 1 | 2000 | 419 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2022 | 769 | 0.030 |
Why?
| | Coronavirus Infections | 1 | 2021 | 383 | 0.030 |
Why?
| | Length of Stay | 1 | 2021 | 1349 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1490 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2007 | 8333 | 0.030 |
Why?
| | Pandemics | 1 | 2023 | 1707 | 0.030 |
Why?
| | Registries | 2 | 2021 | 2406 | 0.030 |
Why?
| | Angiography | 1 | 2015 | 208 | 0.030 |
Why?
| | Wounds, Gunshot | 1 | 1997 | 258 | 0.020 |
Why?
| | Suicide, Attempted | 1 | 1997 | 423 | 0.020 |
Why?
| | Shock | 1 | 2014 | 110 | 0.020 |
Why?
| | Contrast Media | 1 | 2015 | 497 | 0.020 |
Why?
| | Lower Extremity | 1 | 2016 | 445 | 0.020 |
Why?
| | Unnecessary Procedures | 1 | 2012 | 54 | 0.020 |
Why?
| | APACHE | 1 | 2012 | 68 | 0.020 |
Why?
| | Blood Coagulation Tests | 1 | 2012 | 72 | 0.020 |
Why?
| | Echocardiography | 1 | 2015 | 647 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2012 | 318 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2012 | 428 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2013 | 1044 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 5905 | 0.020 |
Why?
| | Factor Xa Inhibitors | 1 | 2012 | 194 | 0.020 |
Why?
| | Radiography | 1 | 2012 | 852 | 0.020 |
Why?
| | Bundle-Branch Block | 1 | 2009 | 37 | 0.020 |
Why?
| | Tachycardia | 1 | 2009 | 57 | 0.020 |
Why?
| | Likelihood Functions | 1 | 2009 | 138 | 0.020 |
Why?
| | Chest Pain | 1 | 2010 | 99 | 0.020 |
Why?
| | Thrombophilia | 1 | 2010 | 89 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 6066 | 0.020 |
Why?
| | Child | 2 | 2007 | 22707 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1300 | 0.020 |
Why?
| | Wounds and Injuries | 1 | 1997 | 961 | 0.020 |
Why?
| | Clinical Competence | 1 | 2016 | 1243 | 0.020 |
Why?
| | Databases as Topic | 1 | 2008 | 71 | 0.020 |
Why?
| | ROC Curve | 1 | 2008 | 617 | 0.020 |
Why?
| | Age Factors | 1 | 2012 | 3342 | 0.010 |
Why?
| | Time Factors | 1 | 2015 | 7123 | 0.010 |
Why?
| | Sex Factors | 1 | 2010 | 2105 | 0.010 |
Why?
| | Quality Improvement | 1 | 2012 | 1295 | 0.010 |
Why?
| | Obesity | 1 | 2015 | 3116 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2012 | 2970 | 0.010 |
Why?
| | Young Adult | 1 | 2013 | 14219 | 0.010 |
Why?
| | Age Distribution | 1 | 1997 | 403 | 0.010 |
Why?
| | Sex Distribution | 1 | 1997 | 387 | 0.010 |
Why?
| | Self-Injurious Behavior | 1 | 1997 | 141 | 0.010 |
Why?
| | Survival Rate | 1 | 1997 | 2090 | 0.010 |
Why?
| | Firearms | 1 | 1997 | 436 | 0.000 |
Why?
| | Incidence | 1 | 1997 | 2923 | 0.000 |
Why?
| | Mental Disorders | 1 | 1997 | 1163 | 0.000 |
Why?
| | Child, Preschool | 1 | 1997 | 11853 | 0.000 |
Why?
|
|
Nordenholz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|